These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 38702933)

  • 41. Neuroprotective effects of osmotin in Parkinson's disease-associated pathology via the AdipoR1/MAPK/AMPK/mTOR signaling pathways.
    Park JS; Choe K; Lee HJ; Park TJ; Kim MO
    J Biomed Sci; 2023 Aug; 30(1):66. PubMed ID: 37568205
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long Noncoding RNA POU3F3 and α-Synuclein in Plasma L1CAM Exosomes Combined with β-Glucocerebrosidase Activity: Potential Predictors of Parkinson's Disease.
    Zou J; Guo Y; Wei L; Yu F; Yu B; Xu A
    Neurotherapeutics; 2020 Jul; 17(3):1104-1119. PubMed ID: 32236821
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reelin protects against pathological α-synuclein accumulation and dopaminergic neurodegeneration after environmental enrichment in Parkinson's disease.
    Cho E; Kim K; Kim H; Cho SR
    Neurobiol Dis; 2022 Dec; 175():105898. PubMed ID: 36270619
    [TBL] [Abstract][Full Text] [Related]  

  • 44. α-Synuclein and Glia in Parkinson's Disease: A Beneficial or a Detrimental Duet for the Endo-Lysosomal System?
    Filippini A; Gennarelli M; Russo I
    Cell Mol Neurobiol; 2019 Mar; 39(2):161-168. PubMed ID: 30637614
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Targeting Microglial α-Synuclein/TLRs/NF-kappaB/NLRP3 Inflammasome Axis in Parkinson's Disease.
    Li Y; Xia Y; Yin S; Wan F; Hu J; Kou L; Sun Y; Wu J; Zhou Q; Huang J; Xiong N; Wang T
    Front Immunol; 2021; 12():719807. PubMed ID: 34691027
    [TBL] [Abstract][Full Text] [Related]  

  • 46. FcγRIIB mediates the inhibitory effect of aggregated α-synuclein on microglial phagocytosis.
    Choi YR; Kang SJ; Kim JM; Lee SJ; Jou I; Joe EH; Park SM
    Neurobiol Dis; 2015 Nov; 83():90-9. PubMed ID: 26342897
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Microglial LRRK2-mediated NFATc1 attenuates α-synuclein immunotoxicity in association with CX3CR1-induced migration and the lysosome-initiated degradation.
    Feng L; Lo H; Hong Z; Zheng J; Yan Y; Ye Z; Chen X; Pan X
    Glia; 2023 Sep; 71(9):2266-2284. PubMed ID: 37300531
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dopamine signaling modulates microglial NLRP3 inflammasome activation: implications for Parkinson's disease.
    Pike AF; Longhena F; Faustini G; van Eik JM; Gombert I; Herrebout MAC; Fayed MMHE; Sandre M; Varanita T; Teunissen CE; Hoozemans JJM; Bellucci A; Veerhuis R; Bubacco L
    J Neuroinflammation; 2022 Feb; 19(1):50. PubMed ID: 35172843
    [TBL] [Abstract][Full Text] [Related]  

  • 49. microRNA-155 Regulates Alpha-Synuclein-Induced Inflammatory Responses in Models of Parkinson Disease.
    Thome AD; Harms AS; Volpicelli-Daley LA; Standaert DG
    J Neurosci; 2016 Feb; 36(8):2383-90. PubMed ID: 26911687
    [TBL] [Abstract][Full Text] [Related]  

  • 50. α-Synuclein impairs ferritinophagy in the retinal pigment epithelium: Implications for retinal iron dyshomeostasis in Parkinson's disease.
    Baksi S; Singh N
    Sci Rep; 2017 Oct; 7(1):12843. PubMed ID: 28993630
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lysosomal response in relation to α-synuclein pathology differs between Parkinson's disease and multiple system atrophy.
    Puska G; Lutz MI; Molnar K; Regelsberger G; Ricken G; Pirker W; Laszlo L; Kovacs GG
    Neurobiol Dis; 2018 Jun; 114():140-152. PubMed ID: 29505813
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The critical role of Nramp1 in degrading α-synuclein oligomers in microglia under iron overload condition.
    Wu KC; Liou HH; Kao YH; Lee CY; Lin CJ
    Neurobiol Dis; 2017 Aug; 104():61-72. PubMed ID: 28476637
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The circadian clock protein Rev-erbα provides neuroprotection and attenuates neuroinflammation against Parkinson's disease via the microglial NLRP3 inflammasome.
    Kou L; Chi X; Sun Y; Han C; Wan F; Hu J; Yin S; Wu J; Li Y; Zhou Q; Zou W; Xiong N; Huang J; Xia Y; Wang T
    J Neuroinflammation; 2022 Jun; 19(1):133. PubMed ID: 35668454
    [TBL] [Abstract][Full Text] [Related]  

  • 54. TREM2 deficiency aggravates α-synuclein-induced neurodegeneration and neuroinflammation in Parkinson's disease models.
    Guo Y; Wei X; Yan H; Qin Y; Yan S; Liu J; Zhao Y; Jiang F; Lou H
    FASEB J; 2019 Nov; 33(11):12164-12174. PubMed ID: 31370707
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recombinant pro-CTSD (cathepsin D) enhances SNCA/α-Synuclein degradation in α-Synucleinopathy models.
    Prieto Huarcaya S; Drobny A; Marques ARA; Di Spiezio A; Dobert JP; Balta D; Werner C; Rizo T; Gallwitz L; Bub S; Stojkovska I; Belur NR; Fogh J; Mazzulli JR; Xiang W; Fulzele A; Dejung M; Sauer M; Winner B; Rose-John S; Arnold P; Saftig P; Zunke F
    Autophagy; 2022 May; 18(5):1127-1151. PubMed ID: 35287553
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association between SGK1 and α-synuclein in skeletal muscle in an MPTP-induced Parkinson's disease model.
    Heo EJ; Lee Y; Hyung Seo M; Yeo S
    Neurosci Lett; 2023 Sep; 814():137464. PubMed ID: 37634811
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Autophagy-dependent removal of α-synuclein: a novel mechanism of GM1 ganglioside neuroprotection against Parkinson's disease.
    Guo YL; Duan WJ; Lu DH; Ma XH; Li XX; Li Z; Bi W; Kurihara H; Liu HZ; Li YF; He RR
    Acta Pharmacol Sin; 2021 Apr; 42(4):518-528. PubMed ID: 32724177
    [TBL] [Abstract][Full Text] [Related]  

  • 58. α-synuclein suppresses microglial autophagy and promotes neurodegeneration in a mouse model of Parkinson's disease.
    Tu HY; Yuan BS; Hou XO; Zhang XJ; Pei CS; Ma YT; Yang YP; Fan Y; Qin ZH; Liu CF; Hu LF
    Aging Cell; 2021 Dec; 20(12):e13522. PubMed ID: 34811872
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Alpha-Synuclein Preformed Fibrils Induce Cellular Senescence in Parkinson's Disease Models.
    Verma DK; Seo BA; Ghosh A; Ma SX; Hernandez-Quijada K; Andersen JK; Ko HS; Kim YH
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359864
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cholecystokinin and glucagon-like peptide-1 analogues regulate intestinal tight junction, inflammation, dopaminergic neurons and α-synuclein accumulation in the colon of two Parkinson's disease mouse models.
    Su Y; Liu N; Zhang Z; Li H; Ma J; Yuan Y; Shi M; Liu J; Zhao Z; Zhang Z; Holscher C
    Eur J Pharmacol; 2022 Jul; 926():175029. PubMed ID: 35584709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.